, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Wu L, Parekh VV, Gabriel CL, Bracy DP, Marks-Shulman PA, Tamboli RA, Kim S, Mendez-Fernandez YV, Besra GS, Lomenick JP, Williams B, Wasserman DH, Van Kaer L (2012) Proc Natl Acad Sci U S A 109(19): E1143-52
    › Primary publication · 22493234 (PubMed) · PMC3358828 (PubMed Central)
  2. T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. Tousif S, Singh Y, Prasad DV, Sharma P, Van Kaer L, Das G (2011) PLoS One 6(5): e19864
    › Primary publication · 21589883 (PubMed) · PMC3093409 (PubMed Central)
  3. Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens. Dragovic SM, Hill T, Christianson GJ, Kim S, Elliott T, Scott D, Roopenian DC, Van Kaer L, Joyce S (2011) J Immunol 186(12): 6683-92
    › Primary publication · 21572029 (PubMed) · PMC3537507 (PubMed Central)
  4. Organ-specific features of natural killer cells. Shi FD, Ljunggren HG, La Cava A, Van Kaer L (2011) Nat Rev Immunol 11(10): 658-71
    › Primary publication · 21941294 (PubMed) · PMC3620656 (PubMed Central)
  5. NKT cell costimulation: experimental progress and therapeutic promise. van den Heuvel MJ, Garg N, Van Kaer L, Haeryfar SM (2011) Trends Mol Med 17(2): 65-77
    › Primary publication · 21087900 (PubMed) · PMC3616392 (PubMed Central)
  6. Natural killer T cells in health and disease. Wu L, Van Kaer L (2011) Front Biosci (Schol Ed) : 236-51
    › Primary publication · 21196373 (PubMed) · PMC3626278 (PubMed Central)
  7. Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule. Huang Y, Park Y, Wang-Zhu Y, Larange A, Arens R, Bernardo I, Olivares-Villagómez D, Herndler-Brandstetter D, Abraham N, Grubeck-Loebenstein B, Schoenberger SP, Van Kaer L, Kronenberg M, Teitell MA, Cheroutre H (2011) Nat Immunol 12(11): 1086-95
    › Primary publication · 21964609 (PubMed) · PMC3197978 (PubMed Central)
  8. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production. Goettel JA, Scott Algood HM, Olivares-Villagómez D, Washington MK, Chaturvedi R, Wilson KT, Van Kaer L, Polk DB (2011) Gastroenterology 140(1): 265-74
    › Primary publication · 20875416 (PubMed) · PMC3008308 (PubMed Central)
  9. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Van Kaer L, Parekh VV, Wu L (2011) Immunotherapy 3(1): 59-75
    › Primary publication · 21174558 (PubMed)
  10. Invariant natural killer T cells: bridging innate and adaptive immunity. Van Kaer L, Parekh VV, Wu L (2011) Cell Tissue Res 343(1): 43-55
    › Primary publication · 20734065 (PubMed) · PMC3616393 (PubMed Central)